2 completed. 2 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 2 | Completed 2 |
Follow SARS-CoV2 Infection: new trials by email Literature Review of SARS-CoV2 Infection trials Research Report on SARS-CoV2 Infection
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| RECOVAC Repeated Vaccination Study mRNA-1273, Ad26.COV2.S vaccine - Covid19, Kidney Diseases | Phase 4 | Completed | University Medical Center Groningen | 336 | 2021-10-21 | 2022-03-29 |
| SARS-CoV-2 Immune Responses After COVID-19 Therapy and Subsequent Vaccine Study-provided Moderna mRNA-1273 COVID-19 vaccine, Community-provided Moderna mRNA-1273 COVID-19 Vaccine, Community-Provided Pfizer-BioNTech BNT162b2 COVID-19 Vaccine - Covid19, SARS-CoV2 Infection | Phase 4 | Completed | National Institute of Allergy and Infectious Diseases (NIAID) | 43 | 2021-07-09 | 2023-05-24 |
COVID-19 (2) · Kidney Diseases (1)
Coronaviridae Infections (2) · Coronavirus Infections (2) · Infections (2) · Lung Diseases (2) · Nidovirales Infections (2) · Pneumonia (2) · Pneumonia, Viral (2) · RNA Virus Infections (2) · Respiratory Tract Diseases (2) · Respiratory Tract Infections (2) · Virus Diseases (2) · Female Urogenital Diseases (1) · Female Urogenital Diseases and Pregnancy Complications (1) · Male Urogenital Diseases (1) · Urogenital Diseases (1)
2019-nCoV Vaccine mRNA-1273 (1) · Ad26COVS1 (1)
National Institute of Allergy and Infectious Diseases (NIAID) (1) · University Medical Center Groningen (1)
Netherlands (1) · United States (1)
David Smith, MD, MAS (1) · Jan-Stephan F Sanders, MD PhD (1)